Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Multiple organ dysfunction induced by alprostadilum in a patient diagnosed with scleroderma (systemic sclerosis)

Show simple item record

dc.contributor.author Baetu, Alexandru Emil
dc.contributor.author Miron, Andreea-Iuliana
dc.contributor.author Punga, Oana Mihaela
dc.date.accessioned 2020-07-02T07:36:35Z
dc.date.available 2020-07-02T07:36:35Z
dc.date.issued 2016
dc.identifier.citation BAETU, Alexandru Emil, MIRON, Andreea-Iuliana, PUNGA, Oana Mihaela. Multiple organ dysfunction induced by alprostadilum in a patient diagnosed with scleroderma (systemic sclerosis). In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p. 12-13. en_US
dc.identifier.isbn 978-9975-3028-3-8.
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/10839
dc.description University of Medicine and Pharmacy Targu Mures, Romania, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016 en_US
dc.description.abstract Introduction: Painful, slow-healing ulcers of the fingers are most common in patients with progressive systemic sclerosis. Prostaglandine E1(PGE1) is a vasodilatator that has been found to reduce the pain of the severe periphereal arterisclerotic vascular disease and to promote healing of the accompanying ulcers. Clinical case: We present the case of a 46-years old, female, allergic to Hymenoptera venom, and witch in 2010 received swine flu vaccine. In october 2010, she reach on the departament of Rheumatology, Targu Mures accusing pain and swelling in the extremities, skin changes at the same level accompanied by vasomotor disturbances at cold. Having in mind this clinical appearance of skin, typical for scleroderma, Associated with the mesenchymal nonspecific inflammatory syndrome proven by laboratory test, with increased antibody titer (antinuclear antibodies-ANA: 45.2 UI/ml and topoisomerase-I antibodies-anti Scl 70: 39.5 UI/ml) and after radiographic appearance of early resorption of the distal phalanx, IV finger, right hand is given a diagnosis of progressive systemic scleroderma and we have initiated a background treatment with methotrexate. But after two months the disease progresses rapidly with necrotizing vasculitis and pulmonary injury. So we initiated a treatment with cyclophosphamide 600 mg intravenously with favorable evolution until October 2011 when it stopped due to a suspected hemorrhagic cystitis, and when peripheral ischemia occur we decide to introduce back azathioprine in the treatment plan but with modest results resuming the treatment with Cyclophosphamide in May 2012, which was Associated with Alprostadilum and in February 2013reenter Methotrexate. In january 2014,after the treatment with Alprostadilum, the patient suddenly accuse chills, low grade fever, muscular pain, without auscultatory lung changes, arrhythmic heart sounds, with ischemic changes on electrocardiogram, rising the suspicion of an acute coronary syndrome, but which was rejected after cardiological examination. Subsequently, after two days, the patient presents coffee grounds vomiting for which was made an upper gastrointestinal endoscopy in emergency, which shows no active bleeding source. Concidering progressive hemodynamic alterations, the patient is transferred in Gastroenterology Clinic where is established the diagnosis of acute gastric ulcer with upper gastrointestinal bleeding. After 2 weeks, the patient presents in the emergency room in bad general condition with necrotic changes in the fingers and she was hospitalized to the intensive care unit with inflammatory syndrome, marked anemia, hepatic and renal failure, pleural effusion fluid with cytopathology diagnosis of atypical cells and suspected neoplastic process having a rapidly evolution to death.In conclusion even if we considered all aspects and risk factors related to the patient’s disease, when we prescribe Alprostadilum we should expect to face a tragic outcome. en_US
dc.language.iso en en_US
dc.publisher MedEspera en_US
dc.subject alprostadilum en_US
dc.subject scleroderma en_US
dc.subject organ dysfunction en_US
dc.subject.ddc 61:378.661(478-25)(082) en_US
dc.title Multiple organ dysfunction induced by alprostadilum in a patient diagnosed with scleroderma (systemic sclerosis) en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2016
    The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics